Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Cited by (787)

Items 601–700 of 787

  1. Tratamiento de la enfermedad de Alzheimer
    Diego André Dávila Sánchez, N. Bravo Quelle, J. Miranda, Javier Olazarán · 2015 · Medicine - Programa de Formación Médica Continuada Acreditado
  2. Efficacy of Doll thErapy compared with standard treatment in the control of behavioral and psychologic Symptoms and CaRegIver Burden in dEmentia: DESCRIBE a randomized, controlled study
    Massimiliano Massaia, Maria Garro, Valeria Quaranta, Elisa Calvi, Francesca Santagata, Patrizia D’Amelio · 2021 · International Journal of Aging Research
  3. Alzheimer Disease and Other Dementias
    Richard M. Whalen · 2022 · Springer eBooks
  4. Prescribing drugs for Alzheimer's disease in primary care: managing cognitive symptoms
    2014 · Drug and Therapeutics Bulletin
  5. Neuropharmacology of Dementias
    Gerhard N. Ransmayr · 2022 · Springer eBooks
  6. Medicinal Cannabis for Alzheimer's Disease
    Genevieve Z. Steiner, Madilyn Coles, Kayla M. Jaye, Najwa‐Joelle Metri, Ali S Butt, Katerina Christofides, Jackson McPartland, Zainab Al-Modhefer, Diana Karamacoska, Ethan B. Russo et al. · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  7. Pharmacotherapy in Alzheimer’s disease and other dementias in practical settings: which drug, when and for whom?
    Marcin Wojtera, Tomasz Sobów · 2014 · Aktualności Neurologiczne
  8. Drug therapies for Alzheimer's disease
    Emma Louise Cunningham, Anthony Peter Passmore · 2013 · British Journal of Mental Health Nursing
  9. Current and Prospective Treatments for Alzheimer's Disease (and Other Neurodegenerative Diseases)
    Steve Pedrini, Mike Morici, Ralph Nigel Martins · 2019 · Wiley eBooks
  10. Efficiency of Donepezil in Elderly Patients Undergoing Orthopaedic Surgery Due To Underlying Post-Operative cognitive Dysfunction: Study Protocol for A Multicentre Randomised Controlled Trial
    Huichen Zhu, Cong Lu, Yi Chen, Shaoyi Chen, Lingke Chen, Zhenling Huang, Jie Zhou, Jie Xiao, Yonglei Huang, Diansan Su · 2021 · Research Square
  11. Differential response to Donepezil in MRI subtypes of mild cognitive impairment
    Patricia Diaz‐Galvan, Giulia Lorenzon, Rosaleena Mohanty, Gustav Mårtensson, Enrica Cavedo, Simone Lista, Andrea Vergallo, Kejal Kantarci, Harald Juergen Hampel, Bruno Dubois et al. · 2023 · Research Square
  12. Bypass the Brain: Deep Cervical Lymphatic-Venous Anastomosis Restores the Default Mode Network in Late-stage Alzheimer's Disease
    Haishuo Xia, Jingyu Chen, Xianfei Yang, Zhiming Zhen, Chenghai Zuo, Chong Li, Feilong Wang, Rui Wang, Xize Jia, Zhirui Zhang et al. · 2025 · Research Square
  13. A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory
    Paul Mũtuanyingĩ Mũrĩithi · 2014 · Research Explorer (The University of Manchester)
  14. Médecin coordinateur en EHPAD et iatrogénie : évaluation d’une pratique professionnelle concernant l’association inappropriée anticholinestérasique/anticholinergique
    Guillaume Sacco, G. Dosa-Toader, G. Marro, P. Balard, Sebastien Gonfrier, Olivier Guérin · 2014 · Les cahiers de l année gérontologique
  15. Screening for and Treating Dementia
    Erik Rifkin, Andrew Lazris · 2014 · Springer eBooks
  16. Emerging Treatments in Alzheimer's Disease
    Abigail Harrelson · 2012 · Language arts journal of Michigan
  17. Cognitive Enhancers and Treatments for Alzheimer's Disease
    D. P. Devanand · 2015 · Wiley eBooks
  18. Elderly, Health of the
    Amit Arora, Andrew O'Neill · 2014 · The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society
  19. Cambios en la alerta social respecto a los trastornos cognitivos en los últimos 20 años. Influencia de los medios de comunicación
    Marcelo E. Katz, Jesica M. Olguín, Paula Terraza, Carlos Alberto Mangone · 2015 · Neurología Argentina
  20. Dementie, meer dan MMSE en casemanager!
    PAUL L. J. DAUTZENBERG · 2012 · Huisarts en Wetenschap
  21. Retention rate of cholinesterase inhibitors and memantine in Alzheimer's disease: A retrospective survey in a community-dwelling cohort
    Tapani Keränen, E. Immonen, Hanna Kuusisto · 2014 · European Geriatric Medicine
  22. Tratamiento de la demencia
    Céline Guillemaud, Veronique Faucounau, Sandrine Greffard, Marc Verny · 2013 · EMC - Tratado de Medicina
  23. Interview: Future of Dementia Care: an Economic Perspective
    Martin Richard John Knapp · 2013 · Neurodegenerative Disease Management
  24. Protocolo de tratamiento de la demencia
    Javier Olazarán, Diego André Dávila Sánchez, E. Navarro Merino, J Herrera · 2015 · Medicine - Programa de Formación Médica Continuada Acreditado
  25. Managing Memory Impairment in Patients With Alzheimer’s Disease
    Aleksandra C. Stark, Andrew E. Budson · 2012 · Neurodegenerative Disease Management
  26. Therapeutic Class Overview Alzheimer's Agents
    Aricept Odt · 2014
  27. Prise en charge médicamenteuse de la démence sévère en EHPAD : étude transversale sur 215 sujets
    Fanny Leborgne · 2014 · HAL
  28. Analyse descriptive de la prise en charge des patients atteints de la maladie d'Alzheimer au sein de l'unité de soins spécialisée du Centre hospitalier de Beauvais
    Amèle Zaraa · 2015 · HAL
  29. NEWS FROM THE ANA ANNUAL MEETING
    Thomas R. Collins · 2013 · Neurology Today
  30. Hospice Dementia Care
    Richard E. Powers, Heather Herrington · 2015 · Springer eBooks
  31. How Do We Use Symptomatic Drugs to Treat Dementia?
    Takashi Kudo · 2016 · Springer eBooks
  32. en EHPAD : etude transversale sur 215 sujets
    Fanny Leborgne · 2016
  33. Influence of Memantine on Continuous Treatment with Rivastigmine Patches —Retrospective Study Using the Logistic Regression Analysis—
    Yuki Yasutaka, Shinsuke Fujioka, Mariko Terasawa, Hirotomo Shibaguchi, Koujiro Futagami, Shinji Ouma, Yoshio Tsuboi, Hidetoshi Kamimura · 2016 · YAKUGAKU ZASSHI
  34. Treatment of Alzheimer Disease: Stop, Add, or Switch?
    Jonathan Silver · 2012 · Journal watch
  35. Absetzen von Cholinesterasehemmern
    Klaus Häger, Olaf Krause · 2017 · DNP - Der Neurologe und Psychiater
  36. We would welcome the opportunity to meet with the review panel to discuss these issues in more detail.
    Glenn Rees · 2012
  37. Managing Drug Therapies as Alzheimer Disease Progresses
    Allan S. Brett · 2012 · Journal watch
  38. Psychopharmacologic Agents to Enhance Cognition in Alzheimer’s Disease
    Alireza Atri, Theodore A. Stern · 2015 · Psychiatric Annals
  39. FACULTE DE MEDECINE DE TOURS
    Adrien Lorette · 2012
  40. Cognitive and Non-Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease
    Wai-Jane Lee · 2017 · Scholarship@Western (Western University)
  41. The Effectiveness and Difference of Memantine and Donepezil - Relating to Changes in Cerebral Blood Flow and Clinical Efficacy
    Kiyoshi Kanaya, Haruo Hanyu · 2017 · British Journal of Research
  42. Identification of Modifier Genes in a Mouse Model of
    Natalia-Santos Ferreira, Shifra Ben‐Dor, Timothy Martin Cox, Anthony H. Futerman · 2016
  43. Medikamentöse Alternativen zu Antipsychotika bei Verhaltensstörungen
    Johannes Rosenboom · 2017 · DNP - Der Neurologe und Psychiater
  44. Geriatric Disorders
    Robert E. McCue, Mary Kelleher · 2017 · Wiley eBooks
  45. Bereitschaft zur Teilnahme an gruppennütziger Demenzforschung
    Martin Haupt, Michaela Jänner · 2018 · Der Nervenarzt
  46. Current management tactics for patients with dementia
    A V Medvedeva, O. V. Kosivtsova, Махинов Константин Алексеевич · 2018 · Neurology neuropsychiatry Psychosomatics
  47. Medikamentöse Therapie von kognitiven und Verhaltensstörungen bei Demenz
    Patrick Jung · 2018 · PSYCH up2date
  48. Enfermedad de Alzheimer: clínica y tratamiento
    Oriol Grau‐Rivera, José Luis Molinuevo Guix · 2013 · Elsevier eBooks
  49. Kognitive Störungen
    Egemen Savaskan, Axel Wollmer, Jens Benninghoff · 2017 · Elsevier eBooks
  50. Management of Alzheimer's disease
    Michael K. Rainer, Hermann AM Mucke · 2019 · Hamdan Medical Journal
  51. Die Wirksamkeit hält auch nach dem Übertritt in das schwere Stadium an
    Markus Weih · 2012 · InFo Neurologie + Psychiatrie
  52. Médecin coordinateur en EHPAD et iatrogénie : évaluation d'une pratique professionnelle concernant l'association inappropriée anticholinestérasique/anticholinergique Coordinating Physician in Nursing Home and Inappropriate Drug Prescription: Evaluation of Professional Practice Targeting the Anticholinergic and Anticholinesterase Association
    G. Dosa-Toader, P. Balard, Sebastien Gonfrier, G. Marro, Olivier Guérin, Guillaume Sacco · 2014
  53. Association anticholinergique/anticholinestérasique : étude transversale sur le mésusage médicamenteux concernant 1 367 prescriptions de résidents en EHPAD Anticholinergic/Anticholinesterase Association: Transversal Study on Drug Misuse Concerning 1367 Prescriptions in Nursing Homes
    G. Dosa-Toader, P. Balard, Sebastien Gonfrier, G. Marro, Olivier Guérin, Guillaume Sacco · 2014
  54. Pharmacological Interventions in Older Adults
    Jay J. Patel, Dale W. Smith, John Heafner, Christopher NG, George Thomas Grossberg · 2019 · Springer eBooks
  55. A study of the global effects of Apolipoprotein E using lipidomics
    Jade I. Hawksworth · 2019 · ORCA Online Research @Cardiff (Cardiff University)
  56. Hoffnungen und Rückschläge in der Alzheimer-Therapie
    Frank Jessen · 2019 · DNP - Der Neurologe und Psychiater
  57. Improving the lived experience of dementia transitions
    Neil Drummond, Linda Garcia, Lynn McCleary · 2020 · Elsevier eBooks
  58. Although pharmacological treatment may have beneficial effects in some patients with dementia, it does not reverse the disease process
    Adis Medical Writers · 2014 · Drugs & Therapy Perspectives
  59. Drugs to Treat Dementia
    Ross A. Dunne, Alistair S. Burns · 2020 · Cambridge University Press eBooks
  60. Medikamentöse Therapie von kognitiven und Verhaltensstörungen bei Demenz
    Patrick Jung · 2019 · Geriatrie up2date
  61. Transcranial Magnetic Stimulation in Dementia: From Pathophysiology to Treatment
    Giacomo Koch · 2020 · Springer eBooks
  62. Dementia and usage of N-methyl-d-aspartate receptor antagonists
    Brianna E. Glynn-Servedio · 2020 · Elsevier eBooks
  63. Review of the Pathology, Diagnosis and Treatment for Alzheimer's Disease
    Xiangcheng Liu · 2021 · International Conference on Bioinformatics and Intelligent Computing (BIC)
  64. Dementia
    Thomas E. Finucane · 2020 · Annals of Internal Medicine
  65. Anti-Dementia Medications: Course and Duration of Therapy and Withdrawal Syndromes
    Aylin Yaman, Hakan Yaman · 2021 · Springer eBooks
  66. Therapie von Demenzerkrankungen: Behandlungsstrategien im Alter
    Frank Jessen · 2014 · Der Internist
  67. Neuropharmacology of Dementias
    Gerhard N. Ransmayr · 2021 · Springer eBooks
  68. Antidementiva
    U. Schwabe · 2012 · Springer eBooks
  69. Memantine for Treatment of Dementia
    Thomas H. Müller, Wilfried Kuhn · 2022 · Springer eBooks
  70. Psychopharmakotherapie – klinisch-empirische Grundlagen
    Hans‐Peter Volz, Siegfried F. Kasper, H.‐J. Möller · 2015 · Springer eBooks
  71. Cognitive Enhancers
    William James Deardorff, George Thomas Grossberg · 2018 · Springer eBooks
  72. Management
    Andrew J. Larner · 2014 · Springer eBooks
  73. Gerontopsychiatrie
    Bernd Ibach · 2015 · Springer eBooks
  74. Behavioral Neurology
    Alejandra Sánchez López, Marcela Mar, Bruce L. Miller · 2021 · Springer eBooks
  75. Drug development and Alzheimer's disease
    Julien Delrieu, Bruno J. Vellas · 2022 · Wiley eBooks
  76. Principles of Pharmacology in Dementia
    Francisco Assis Carvalho Vale, Judith Thomas Tayra, Carina Tellaroli Spedo · 2022 · Springer eBooks
  77. Current Treatments for Alzheimer’s Disease
    Mary Sano, Judith Neugroschil · 2017 · Oxford University Press eBooks
  78. Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 13. Auflage
    2017 · Elsevier eBooks
  79. Demenzerkrankungen
    Ingo Kilimann, Stefan Johannes Teipel · 2019 · Elsevier eBooks
  80. Antidementiva
    U. Schwabe · 2016 · Springer eBooks
  81. Faculty Opinions recommendation of Prions activate a p38 MAPK synaptotoxic signaling pathway.
    John Silke · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  82. Kognitive Störungen
    Egemen Savaskan, Axel Wollmer · 2020 · Elsevier eBooks
  83. M
    2016
  84. Antidementiva
    U. Schwabe · 2019 · Springer eBooks
  85. Reply
    Taim Abdullah Muayqil, Richard M. Camicioli · 2014 · Dementia and Geriatric Cognitive Disorders Extra
  86. Alzheimer’s disease
    Ivan G. Koychev, John Gallacher · 2020
  87. Is It Still Helping?
    Keith A. Josephs, Federico E Rodriguez‐Porcel, Rhonna S. Shatz, Daniel A. Weintraub, Alberto Javier Espay · 2020 · Cambridge University Press eBooks
  88. Dementie
    J.A.H.R. Claassen, Frans R.J. Verhey, Marcel G. M. Olde Rikkert · 2013 · Bohn Stafleu van Loghum eBooks
  89. Antidementiva
    U. Schwabe · 2014 · Springer eBooks
  90. Dementia
    2016
  91. Antidementiva
    Otto Benkert, Hanns Hippius · 2012 · Springer eBooks
  92. Evidence-based management of behavioural and psychological symptoms of dementia
    Anne Corbett, Clive G. Ballard, Byron Creese · 2017 · Oxford University Press eBooks
  93. Pharmacological interventions in mild cognitive impairment and dementia
    Jacques Hugon, Claire Paquet · 2017 · Oxford University Press eBooks
  94. Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 14. Auflage
    2019 · Elsevier eBooks
  95. Antidementiva
    U. Schwabe · 2018 · Springer eBooks
  96. Literaturverzeichnis zu Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 10. Auflage
    2014 · Elsevier eBooks
  97. Antidementiva
    U. Schwabe · 2017 · Springer eBooks
  98. Antidementiva
    U. Schwabe · 2015 · Springer eBooks
  99. Alzheimer's Disease ☆
    Victor W. Henderson, Geoffrey A. Kerchner · 2014 · Elsevier eBooks
  100. Quality of Life of Persons with Dementia
    Rose‐Marie Dröes, Teake P. Ettema, Martin Richard John Knapp, Erik Schokkaert · 2022 · Cambridge University Press eBooks